High-Dose Vitamin B12 Injections: A Cure for Chronic Lymphocytic Leukemia?

Imagine a cancer diagnosis that doesn’t lead to chemotherapy, radiotherapy, or surgery, but instead to a remarkable recovery driven by a simple vitamin. This is the story of a molecular biologist who, diagnosed with chronic lymphocytic leukemia at the age of 59, defied the odds by achieving complete remission using high-dose injections of methylcobalamin, a form of vitamin B12. His journey, detailed in a new case report published in the Cancer Reports journal, highlights a potential new avenue for treating this common type of leukemia, challenging the dogma of conventional approaches and providing further evidence of the effectiveness and safety of natural therapies.

The patient, a former researcher at the prestigious Massachusetts Institute of Technology (MIT) in the United States, was diagnosed in 2007 with early-stage chronic lymphocytic leukemia, a slow-progressing cancer affecting the blood and bone marrow. This form of leukemia often prompts a ‘watch and wait’ strategy, as no standard treatment exists for its early stages. Even later-stage therapies, such as chemotherapy or newer immunotherapies, rarely offer a cure.

Dissatisfied with a passive approach, the patient decided to pursue an experimental path. After specialized testing in Greece to determine his cancer’s genetic profile, he began using a personalized regimen of natural therapies. These included vitamin C, alpha lipoic acid, quercetin, green tea extract, and curcumin, along with daily 1 mg injections of hydroxocobalamin (a form of vitamin B12). For several years this seemed to stabilize his condition, with his lymphocyte counts – which were elevated due to the chronic lymphocytic leukemia – remaining steady but not decreasing.

The turning point and breakthrough

The turning point came in 2014 when, after noticing a gradual rise in his lymphocyte counts, the patient switched to using the methylcobalamin form of vitamin B12 at a significantly higher dose of 50 mg daily, administered intramuscularly. This change was informed by research suggesting that methylcobalamin has potent anti-cancer properties. The safety of such doses is well-established, with studies showing no adverse effects even at the higher amounts used for conditions such as multiple sclerosis. Within weeks, the patient’s lymphocyte counts began to drop, inching toward normal.

But the real breakthrough occurred in 2019, when a severe urinary tract infection struck. As the infection resisted initial antibiotics and triggered complications, the man temporarily tripled his methylcobalamin dose to 150 mg daily. The results were dramatic. By the following month, his lymphocyte counts had normalized. Subsequent tests in 2023 and 2024 confirmed no trace of chronic lymphocytic leukemia. In effect, the patient was cured.

Discussing the story, Carmen Wheatley, the case report’s author, stresses the importance of using the correct form and dosage of vitamin B12. While the patient’s initial use of low-dose hydroxocobalamin stabilized his condition, it did not achieve remission. Only the switch to high-dose methylcobalamin, backed by decades of research showing its superior anti-cancer effects, led to a cure. Studies show that high doses of the active coenzyme forms of vitamin B12, methylcobalamin and adenosylcobalamin, can overwhelm cancer cells’ defenses, promoting apoptosis (cell death) and enhancing immune surveillance.

Profound implications

The implications of this well-documented case report are potentially profound. Chronic lymphocytic leukemia, while often manageable, lacks a definitive cure, and spontaneous remissions are exceedingly rare, occurring in just 0.6 percent of cases. Moreover, conventional treatments carry significant side effects and don’t work for everybody. The use of effective, safe, natural, affordable options like methylcobalamin could ultimately therefore transform early-stage chronic lymphocytic leukemia management, and potentially even other blood cancers as well. Towards this goal, scientists at the Dr. Rath Research Institute have already demonstrated that a specific combination of micronutrients can modify all aspects of leukemia, including inhibiting growth and inflammation factors.

Without doubt, this patient’s triumph offers a beacon of hope. Now aged 76, he remains cancer-free, a testament to the power of informed self-experimentation and the potential of vitamin B12. Could this humble nutrient hold the key to helping unlock cures for rare and difficult-to-treat cancers? Only time and further research will tell, but the possibility is undeniably exciting.

• Bio
• Latest Posts

Paul Anthony Taylor

Executive Director of the Dr. Rath Health Foundation and one of the coauthors of our explosive book, “The Nazi Roots of the ‘Brussels EU'”, Paul is also our expert on the Codex Alimentarius Commission and has had eye-witness experience, as an official observer delegate, at its meetings.

Prior to joining the Foundation, Paul's background was in the music industry, where he worked as a keyboard player and programmer with artists including Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas, and Primal Scream.

He first became interested in natural health after falling ill with a chronic fatigue syndrome-related disorder in 1991 and subsequently making a full recovery through the use of natural health therapies. After meeting Dr. Rath and Dr. Niedzwiecki at an anti-Codex rally in Berlin in 2002, Paul was inspired to make a life-changing decision to leave the music industry to work for the Foundation and help defend the right of patients worldwide to have free access to natural health approaches.

You can find Paul on Twitter at @paulanthtaylor

Der Executive Director der Dr. Rath Health Foundation ist einer der Koautoren des explosiven Buchs „Die Nazi-Wurzeln der Brüsseler EU“. Paul ist auch unser Experte zum Thema „Codex Alimentarius-Kommission“ und hat Augenzeugenerfahrung als offizieller beobachtender Teilnehmer bei diesen Treffen.

Bevor er seine Arbeit bei der Stiftung antrat war Paul in der Musikindustrie aktiv. Er arbeitete als Keyboard-Spieler und Programmierer mit Künstlern wie Paul McCartney, Bryan Ferry, Bill Withers, the Verve, Texas und Primal Scream.

Sein Interesse an natürlicher Gesundheit wuchs, als er 1991 an Störungen erkrankte, die aus einem chronischen Erschöpfungssyndrom resultierten. Durch natürliche Gesundheitstherapien wurde er schließlich vollständig geheilt. Ein Treffen 2002 mit Dr. Rath und Dr. Niedzwiecki bei einer Anti-Codex-Demonstration in Berlin inspirierte ihn zu einer lebensverändernden Entscheidung und er verließ die Musikindustrie um für die Stiftung zu arbeiten und das Recht der Patienten zu verteidigen, weltweit freien Zugang zu natürlichen Gesundheitsverfahren zu haben.

Auf Twitter ist Paul unter @paulanthtaylor zu finden.

Latest posts by Paul Anthony Taylor (see all)

• Ebola Returns: Twelve Years After Dr. Rath’s Warning, Has the World Learned Nothing? - May 22, 2026
• Coenzyme Q10 and High Blood Pressure: The Overlooked Micronutrient That Doctors Can No Longer Ignore - May 15, 2026
• Growing Evidence of the Benefits of Vitamin D in Multiple Sclerosis - May 8, 2026
• Bilderberg 2026: When Power Meets in Secret, Democracy Pays the Price - April 24, 2026
• Europe’s ‘War on Vitamins’ Returns: How European Union Restrictions Risk Deepening a Silent Public Health Crisis - April 17, 2026